查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870606

生物可吸收植入市场按材料类型、应用、产品类型和最终用户划分 - 全球预测 2025-2032

Bioresorbable Implants Market by Material Type, Application, Product Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物可吸收植入市场将成长至 100.7 亿美元，复合年增长率为 7.41%。

关键市场统计数据
基准年 2024 56.8亿美元
预计年份：2025年 60.9亿美元
预测年份 2032 100.7亿美元
复合年增长率 (%) 7.41%

生物可吸收植入代表了医疗设备设计的模式转移。这些材料旨在发挥治疗功能，其设计目的是在完成治疗后安全降解并被人体吸收。这些技术融合了材料科学、聚合物化学和器械工程，可提供临时结构支撑、局部药物传输或促进组织再生的生物活性支架。随着临床越来越重视最大限度减少异物长期留存的解决方案，生物可吸收植入在多个专科领域取得了进展，从介入心臟病学到整形外科重组和眼科药物输送。

临床医生和医疗器材研发人员正就一种实证方法达成共识，将降解动力学与生物癒合时间线相匹配。可吸收技术的监管途径已日趋成熟，生产和灭菌製程也已优化，以维持材料的完整性和临床性能。同时，聚合物化学家、生物医学工程师和外科医生之间的多学科合作正在加速推进，设计迭代正在进行中，旨在确保治疗期间的耐久性和治疗后可预测的吸收。

从概念到临床应用，不仅需要令人信服的临床结果，还需要可重复的生产流程、可扩展的供应链以及明确的报销标准。当相关人员评估各种机会时，临床需求、材料特性和商业化准备之间的策略性相互作用，将决定哪些可吸收解决方案能够从研究阶段走向临床应用。本报告对这些因素进行了深入而全面的分析，旨在为策略规划和投资决策提供参考。

新兴的科学、临床和製造趋势正在迅速改变生物可吸收植入植入方案的开发和应用。

随着技术进步和临床需求的融合，生物可吸收植入的模式正在重塑，其设计、测试和应用方式也随之改变。聚合物化学的创新催生了诸如具有可调降解速率和机械性能的脂肪族聚酯等材料，使植入物能够更精准地匹配组织癒合的时间线。积层製造和微加工技术实现了复杂的几何形状和孔隙率梯度，从而能够控制吸收动力学并增强组织整合。这些进步正在转化为新一代植入，它们功能强大，同时在关键的恢復阶段中具有临时性。

近期关税政策变化如何影响生物可吸收植入製造商的供应链韧性、筹资策略和商业计划

关键市场关税政策的变化可能对生物可吸收植入製造商的供应链、筹资策略和商业计划产生重大影响。随着2025年关税调整的实施，医疗设备供应商和零件製造商正在重新审视其全球采购结构，以降低成本波动，并确保关键原材料和成品的稳定供应。在进口聚合物、基材和灭菌服务关税推高到岸成本的地区，企业正在考虑采取近岸外包、供应商多元化和垂直整合等策略性应变措施。

结合材料科学、临床应用、产品类型和终端用户趋势的详细細項分析，指导产品开发和商业化选择。

关键细分市场分析揭示了重要的技术和商业性差异，这些差异决定了产品的适用性、临床应用性和研发重点。材料选择仍然至关重要；聚己内酯、Polyglycolic乙醇酸、聚乳酸和聚乳酸-羟基乙酸共聚物各自具有不同的降解特性、机械性能和加工要求，这些都会影响器械的设计选择和临床适应症。设计人员必须选择合适的聚合物，以配合所需的吸收时间和宿主组织反应，确保在所需的治疗週期中保持结构完整性。

比较区​​域趋势如何影响主要全球市场的监管路径、临床应用模式和生产重点

区域趋势对临床应用、监管路径和生产投资有显着影响，从而为每个主要区域创造了独特的策略要务。美洲地区临床试验活动高度集中，心血管和整形外科等专科手术量庞大，并有完善的健保报销体系。这可能加速疗效已获验证的医疗器材进入市场。国内供应链的考量和政策转变也在推动本地製造能力的提升，以降低跨境中断和关税影响的风险。

生物可吸收植入领域领导者的竞争优势和组织要求包括卓越的製造流程、监管策略和临床证据产生。

生物可吸收植入领域由成熟的医疗设备製造商、专业聚合物开发商和专注于特定临床应用的灵活新兴企业组成。产业领导者凭藉其整合材料化学、器材设计和临床证据生成的能力脱颖而出，而新兴企业倾向于凭藉新型材料、创新製造方法或具有显着未满足需求的特定临床领域竞争。随着大型公司利用新型可吸收技术强化其产品组合，以及小型创新者寻求更广泛的市场进入，策略联盟和授权协议十分常见。

製造商可采取的策略重点是协调材料创新、可扩展製造和临床证据生成，以加速材料应用。

为了将技术潜力转化为永续的商业性成功，产业领导者应采取协作策略，整合材料创新、临床检验和供应链韧性。首先，应优先考虑具有可调降解特性和可预测机械性能的材料组合，并投资于将聚合物性能与临床癒合时间联繫起来的转化研究。能够预测生物反应和降解产物的可靠临床前项目可以降低监管风险，并增强临床医生的信心。

采用透明、多方面的研究途径，结合专家访谈、技术资料分析、法规审查、竞争和供应链评估。

本研究结合了对临床专家、材料科学家、医疗设备工程师和采购人员的访谈，并严格审查了监管文件、公开临床试验註册资讯和同行评审文献，从而构建了生物可吸收植入的全貌。在调查方法，本研究着重于将定性专家见解与聚合物性能、降解速率和医疗设备动态的技术分析相结合，以确保商业性应用基于材料科学和临床实际情况。

临床、生产和经济因素的综合考量将决定生物可吸收植入创新能否取得持续的临床和商业性成功。

生物可吸收植入处于材料科学、临床需求和卫生经济学的策略性交汇点，为改善病患预后并减轻长期医疗设备负担提供了一条途径。这些医疗设备的未来取决于研发人员如何有效地将聚合物科学转化为经临床检验的器械，製造商如何确保稳健、高品质的生产能力，以及支付方和医疗服务提供者如何认可并报销其已展现的价值。那些兼具深厚技术专长、严谨的临床试验计画和灵活的供应链策略的机构，将最有优势主导。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将先进聚合物复合材料整合到整形外科植入中，以增强生物吸收控制
  • 用于颅颜重组的患者特异性生物可吸收支架的3D列印
  • 开发用于血管支架中控释药物的奈米纤维增强生物可吸收材料
  • 监管协调工作旨在简化生物可吸收心血管植入的临床核准
  • 介入性心臟病学的进步推动了微创生物可吸收植入输送系统的兴起。
  • 推出用于即时监测组织癒合和植入劣化的智慧生物可吸收感测器
  • 聚合物化学创新者与医疗设备製造商建立策略联盟，共同开发下一代植入

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依材料类型分類的生物可吸收植入市场

  • 聚己内酯
  • Polyglycolic
  • 聚乳酸
  • 聚乳酸-羟基乙酸共聚物

第九章 依应用分類的生物可吸收植入市场

  • 心血管系统
    • 修补补丁
    • 支架
      • 血管支架
    • 血管移植物
      • 冠状动脉移植
      • 週边移植
  • 牙科
    • 骨移植材料
    • 电影
  • 眼科
    • 药物输送
    • 鹰架
    • 缝合线
  • 整形外科
    • 骨再生
      • 接枝
      • 油灰
      • 鹰架
    • 骨折固定
      • 别针
      • 盘子
      • 拧紧
    • 脊椎融合手术
      • 笼
      • 桿
      • 拧紧

第十章 生物可吸收植入市场（依产品类型划分）

  • 药物输送系统
    • 水凝胶
    • 微球
  • 固定装置
    • 别针
    • 盘子
    • 拧紧
  • 鹰架
    • 骨支架
    • 组织支架
  • 缝合线
    • 编织
    • 单丝

第十一章 依最终用户分類的生物可吸收植入市场

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 生物可吸收植入市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 生物可吸收植入市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国生物可吸收植入市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Stryker Corporation
    • B. Braun Melsungen AG
    • Zimmer Biomet Holdings, Inc.
    • Teleflex Incorporated
    • ConMed Corporation
    • Orthofix Medical Inc.
Product Code: MRR-1A1A064C0211

The Bioresorbable Implants Market is projected to grow by USD 10.07 billion at a CAGR of 7.41% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.68 billion
Estimated Year [2025] USD 6.09 billion
Forecast Year [2032] USD 10.07 billion
CAGR (%) 7.41%

Bioresorbable implants represent a paradigm shift in medical device design, where materials engineered to perform a therapeutic function are designed to safely degrade and be absorbed by the body after serving their purpose. These technologies blend materials science, polymer chemistry, and device engineering to deliver temporary structural support, localized drug delivery, or biologically active scaffolding that promotes native tissue regeneration. As clinical practice increasingly prioritizes solutions that minimize long-term foreign body presence, bioresorbable options are advancing across multiple specialties, from cardiovascular interventions to orthopedic reconstruction and ophthalmic drug delivery.

Clinicians and device developers are converging on an evidence-driven approach that balances the kinetics of degradation with the biological timeline of healing. Regulatory pathways have matured to accommodate resorbable technologies, while manufacturing and sterilization processes have been optimized to maintain material integrity and clinical performance. Concurrently, cross-disciplinary collaborations among polymer chemists, biomedical engineers, and surgeons are accelerating design iterations that address durability during the therapeutic window and predictable absorption thereafter.

Transitioning from concept to clinical adoption requires not only compelling clinical outcomes but also reproducible manufacturing, scalable supply chains, and clear reimbursement narratives. As stakeholders evaluate opportunities, the strategic interplay of clinical need, material properties, and commercialization readiness defines which resorbable solutions will move from investigational use to standard of care. This report offers an incisive synthesis of those forces to inform strategic planning and investment decisions.

Emerging scientific, clinical, and manufacturing dynamics that are rapidly transforming the development and adoption of bioresorbable implant solutions

The bioresorbable implant landscape is being reshaped by converging technological advances and clinical imperatives that are changing how devices are conceived, tested, and adopted. Innovations in polymer chemistry are producing materials such as aliphatic polyesters with tunable degradation rates and mechanical profiles, enabling devices that match tissue healing timelines more precisely. Additive manufacturing and microfabrication techniques now permit complex geometries and porosity gradients that enhance tissue integration while controlling resorption kinetics. Together, these advances enable a new generation of implants that are purposefully transient yet functionally robust during critical phases of recovery.

Clinically, the shift toward minimally invasive procedures and outpatient pathways has elevated demand for implants that reduce long-term complications and secondary interventions. Surgeons increasingly embrace devices that support biological healing without leaving permanent hardware, particularly in patient populations where lifelong implants pose risks or complicate imaging and future interventions. At the same time, regulatory frameworks and clinical trial designs have adapted to address device biodegradation, host response, and long-term safety, which streamlines pathways for well-characterized materials and clearly defined performance endpoints.

Economic and operational transformations are also influential. Contract manufacturing organizations and component suppliers are investing in specialized processing capabilities for bioresorbable polymers, while payers and health systems are evaluating total cost of care benefits associated with reduced revision rates. The net effect is a market environment that rewards integrated approaches combining proven materials, scalable manufacturing, and robust clinical evidence, driving rapid maturation of resorbable implant offerings.

How recent tariff policy changes are reshaping supply chain resilience, sourcing strategies, and commercial planning for bioresorbable implant manufacturers

Tariff policy shifts in major markets have the potential to materially influence supply chains, sourcing strategies, and commercial planning for manufacturers of bioresorbable implants. In the wake of tariff adjustments implemented in 2025, device suppliers and component manufacturers have reassessed global procurement footprints to mitigate cost volatility and maintain continuity of critical raw materials and finished goods. Where tariffs raise landed costs for imported polymers, substrates, or sterilization services, firms have evaluated nearshoring, supplier diversification, and vertical integration as strategic responses.

The practical impact extends beyond unit cost. Increased tariffs can lengthen lead times and complicate inventory strategies, prompting manufacturers to increase safety stocks or qualify alternate materials and suppliers. For technology developers, higher cross-border costs incentivize local production of high-value components and may accelerate investments in domestic processing capacity for polymers such as polylactic acid derivatives. Regulatory approvals and quality control systems must keep pace to ensure that rapid supplier changes do not compromise device performance or traceability.

Payers and providers also respond to tariff-driven price shifts by scrutinizing reimbursement pathways and comparative value. In some cases, clinical adoption timelines have been extended while health systems assess whether higher acquisition costs are offset by reductions in long-term complications or reoperation rates. Ultimately, resilient commercial strategies emphasize supply chain transparency, multiple qualified suppliers across geographies, and adaptive contract terms to absorb policy volatility while protecting access to innovative resorbable therapies.

In-depth segmentation analysis linking material science, clinical application, product typology, and end-user dynamics to inform development and commercialization choices

Key segmentation insights reveal critical technical and commercial differences that determine product fit, clinical applicability, and development priorities. Material selection remains foundational, with polycaprolactone, polyglycolic acid, polylactic acid, and polylactic-co-glycolic acid each offering distinct degradation profiles, mechanical characteristics, and processing requirements that influence device design choices and clinical indications. Designers must align polymer selection with the desired resorption timeline and host tissue response to ensure that structural integrity is retained for the required therapeutic window.

Application-driven segmentation highlights the diversity of clinical use cases. In cardiovascular applications, repair patches, stents, and vascular grafts present unique engineering and regulatory demands, where stents may include vascular scaffolds and grafts span coronary and peripheral indications. Dental applications are oriented around bone grafts and membranes that support dental regeneration and implantology. Ophthalmic needs focus on drug delivery vehicles, scaffolds, and sutures that interface with sensitive ocular tissues and require precise degradation control. Orthopedic applications encompass bone regeneration, fracture fixation, and spine fusion; within these, bone regeneration devices include grafts, putty, and scaffolds while fracture fixation leverages pins, plates, and screws and spine fusion employs cages, rods, and screws. Each application imposes distinct mechanical and biological constraints that guide R&D priorities.

Product-type segmentation further refines market opportunity, differentiating drug delivery systems, fixation devices, scaffolds, and sutures. Drug delivery approaches incorporate hydrogels and microspheres to enable localized therapeutic release, whereas fixation devices rely on pins, plates, and screws designed to carry load then resorb. Scaffolds bifurcate into bone scaffolds and tissue scaffolds that provide structural templates for regeneration. Sutures, whether braided or monofilament, must balance handling characteristics with predictable absorption. End-user segmentation across ambulatory surgical centers, clinics, and hospitals shapes purchasing behaviors, inventory needs, and adoption velocity, as institutional capabilities and procedural volumes influence device selection and implementation strategies.

Comparative regional dynamics shaping regulatory pathways, clinical adoption patterns, and manufacturing priorities across major global markets

Regional dynamics exert strong influence on clinical adoption, regulatory pathways, and manufacturing investments, creating distinct strategic imperatives across major geographies. The Americas exhibit concentrated clinical trial activity and significant procedural volumes in specialties such as cardiovascular and orthopedics, supported by established reimbursement frameworks that can accelerate market entry for devices with demonstrated outcomes. Domestic supply chain considerations and policy shifts also incentivize local manufacturing capabilities to reduce exposure to cross-border disruptions and tariff effects.

Europe, Middle East & Africa present a heterogeneous regulatory and healthcare landscape where device approval processes vary by jurisdiction and health technology assessment plays an outsized role in procurement decisions. Reimbursement pathways can be more conservative in parts of this region, promoting rigorous comparative-effectiveness evidence as a prerequisite for widespread adoption. Meanwhile, pockets of rapid adoption exist where clinicians and health systems prioritize minimally invasive and regenerative solutions, creating targeted opportunities for manufacturers able to navigate regional regulatory complexity and deliver compelling clinical value propositions.

Asia-Pacific is characterized by diverse markets ranging from highly advanced healthcare systems to rapidly developing ones, each with unique demands for affordability, scalability, and clinical outcomes. Manufacturing capacity in this region is expanding, and there is growing local demand for innovative implants that align with population health needs. Collaborations between local clinical centers and global developers are increasingly common, enabling both clinical validation and localized product adaptation to meet regulatory and procedural preferences in the region.

Competitive and organizational imperatives that define industry leaders in bioresorbable implants, including manufacturing excellence, regulatory strategy, and clinical evidence generation

Competitive dynamics in the bioresorbable implant sector are driven by a mix of established medical device manufacturers, specialized polymer developers, and agile startups focused on niche clinical applications. Leaders differentiate through integrated capabilities that span material chemistry, device engineering, and clinical evidence generation, while emerging players often compete on novel materials, innovative manufacturing approaches, or targeted clinical niches where unmet needs remain acute. Strategic partnerships and licensing arrangements are common as larger firms seek to augment portfolios with novel resorbable technologies and smaller innovators pursue broader market access.

Manufacturing competency is a critical competitive axis. Firms that invest in validated polymer processing, sterilization protocols compatible with resorbable substrates, and scalable assembly lines gain time-to-market advantages. Quality systems and regulatory know-how are equally important; companies that streamline submission pathways through robust preclinical characterization and early clinical collaborations can accelerate adoption. Additionally, supply chain resilience-including secured sources for medical-grade polymers and backup suppliers for critical components-constitutes a competitive moat against operational disruptions.

Commercial success also depends on clinical and payer engagement. Organizations that proactively generate real-world evidence, demonstrate reductions in reoperation rates or device-related complications, and articulate clear health-economic value propositions are better positioned to achieve reimbursement and clinician adoption. Finally, service models such as surgeon training, procedural support, and data-driven outcomes tracking can amplify market penetration and create differentiated value for customers.

Actionable strategic priorities for manufacturers to align material innovation, scalable manufacturing, and clinical evidence generation to accelerate adoption

Industry leaders should pursue a coordinated strategy that aligns materials innovation, clinical validation, and supply chain resilience to convert technological promise into sustainable commercial success. First, prioritize material portfolios that offer tunable degradation profiles and predictable mechanical performance, and invest in translational studies that link polymer properties to clinical healing timelines. Robust preclinical programs that anticipate host response and degradation byproducts will reduce regulatory risk and build clinician confidence.

Second, strengthen manufacturing and quality systems to support scale-up and to ensure consistent performance across lots. Qualification of multiple qualified suppliers for critical polymers and components, coupled with strategic nearshoring or regional manufacturing footprints, will reduce exposure to tariff-related cost shifts and shipping disruptions. Parallel investments in sterilization validation and packaging technologies tailored for resorbable substrates will preserve device integrity through the supply chain.

Third, design clinical development and market access plans that emphasize real-world evidence and health-economic outcomes. Align trial endpoints with payer requirements and clinician priorities to accelerate reimbursement conversations. Finally, cultivate collaborative commercialization models that include clinician education, procedure-level support, and outcomes monitoring to demonstrate comparative value. By integrating these strategic pillars-materials, manufacturing, clinical evidence, and commercial enablement-organizations can de-risk innovation pathways and accelerate adoption in diverse care settings.

Transparent multi-method research approach combining expert interviews, technical material analysis, regulatory review, and competitive and supply chain assessments

This research synthesizes primary interviews with clinical experts, material scientists, device engineers, and procurement leaders, combined with a rigorous review of regulatory filings, public clinical trial registries, and peer-reviewed literature to build a comprehensive view of the bioresorbable implant landscape. Methodological emphasis was placed on triangulating qualitative insights from subject-matter experts with technical analyses of polymer performance, degradation kinetics, and device biomechanics, ensuring that commercial implications are rooted in material science and clinical realities.

Analytical frameworks included segmentation mapping by material, application, product type, and end-user to surface differences in clinical requirements and adoption dynamics. Supply chain assessments evaluated manufacturing capacity, critical inputs, and policy exposure, including tariff sensitivities and logistical constraints. Competitive profiling assessed organizational capabilities across R&D, manufacturing, regulatory affairs, and commercialization, while regional analysis considered regulatory heterogeneity, payer environments, and clinical practice patterns.

Limitations are acknowledged: the dynamic nature of regulatory decisions and ongoing clinical research means that guidance is based on the best available evidence at the time of report preparation, and stakeholders should incorporate new clinical data and policy developments into decision models. Where appropriate, the research team employed conservative assumptions regarding adoption timelines and prioritized evidence from clinical studies and validated engineering characterizations rather than uncorroborated claims.

Synthesis of clinical, manufacturing, and economic imperatives that determine which bioresorbable implant innovations will achieve durable clinical and commercial success

Bioresorbable implants occupy a strategic intersection of materials science, clinical need, and healthcare economics, offering pathways to improve patient outcomes while reducing long-term device burden. The trajectory of this class of devices will be determined by how effectively developers translate polymer science into clinically validated devices, how manufacturers secure resilient and high-quality production capabilities, and how payers and providers recognize and reimburse demonstrated value. Those organizations that integrate deep technical expertise with rigorous clinical programs and adaptive supply chain strategies will be best positioned to lead.

As the healthcare ecosystem continues to emphasize value-based care and minimally invasive therapies, demand for resorbable solutions that lower reoperation rates and simplify patient management is likely to grow. However, realizing that potential requires coordinated investment in material optimization, regulatory preparedness, and real-world outcomes generation. Stakeholders who move decisively to align these elements will not only unlock clinical benefits but also capture commercial advantage in a landscape where predictability of performance and evidence of value are paramount.

In sum, bioresorbable implants present compelling opportunities for innovation-driven growth, yet success depends on disciplined execution across science, manufacturing, and clinical validation. Organizations that adopt an integrated approach will shape the next wave of resorbable therapies and set new standards for patient-centered device design.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of advanced polymer composites for enhanced bioresorption control in orthopedic implants
  • 5.2. Adoption of 3D printed patient-specific bioresorbable scaffolds for craniofacial reconstruction
  • 5.3. Development of nanofiber reinforced bioresorbable materials for controlled drug delivery in vascular stents
  • 5.4. Regulatory harmonization efforts for streamlining clinical approval of bioresorbable cardiovascular implants
  • 5.5. Rise in minimally invasive delivery systems for bioresorbable implants driven by interventional cardiology advancements
  • 5.6. Implementation of smart bioresorbable sensors for real-time monitoring of tissue healing and implant degradation
  • 5.7. Strategic collaborations between polymer chemistry innovators and medical device firms for next-generation implants

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioresorbable Implants Market, by Material Type

  • 8.1. Polycaprolactone
  • 8.2. Polyglycolic Acid
  • 8.3. Polylactic Acid
  • 8.4. Polylactic-Co-Glycolic Acid

9. Bioresorbable Implants Market, by Application

  • 9.1. Cardiovascular
    • 9.1.1. Repair Patches
    • 9.1.2. Stents
      • 9.1.2.1. Vascular Scaffold
    • 9.1.3. Vascular Grafts
      • 9.1.3.1. Coronary Grafts
      • 9.1.3.2. Peripheral Grafts
  • 9.2. Dental
    • 9.2.1. Bone Grafts
    • 9.2.2. Membranes
  • 9.3. Ophthalmic
    • 9.3.1. Drug Delivery
    • 9.3.2. Scaffolds
    • 9.3.3. Sutures
  • 9.4. Orthopedic
    • 9.4.1. Bone Regeneration
      • 9.4.1.1. Grafts
      • 9.4.1.2. Putty
      • 9.4.1.3. Scaffolds
    • 9.4.2. Fracture Fixation
      • 9.4.2.1. Pins
      • 9.4.2.2. Plates
      • 9.4.2.3. Screws
    • 9.4.3. Spine Fusion
      • 9.4.3.1. Cages
      • 9.4.3.2. Rods
      • 9.4.3.3. Screws

10. Bioresorbable Implants Market, by Product Type

  • 10.1. Drug Delivery Systems
    • 10.1.1. Hydrogels
    • 10.1.2. Microspheres
  • 10.2. Fixation Devices
    • 10.2.1. Pins
    • 10.2.2. Plates
    • 10.2.3. Screws
  • 10.3. Scaffolds
    • 10.3.1. Bone Scaffolds
    • 10.3.2. Tissue Scaffolds
  • 10.4. Sutures
    • 10.4.1. Braided
    • 10.4.2. Monofilament

11. Bioresorbable Implants Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Bioresorbable Implants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bioresorbable Implants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bioresorbable Implants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. Boston Scientific Corporation
    • 15.3.4. Abbott Laboratories
    • 15.3.5. Stryker Corporation
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Zimmer Biomet Holdings, Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. ConMed Corporation
    • 15.3.10. Orthofix Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIORESORBABLE IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIORESORBABLE IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIORESORBABLE IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)

TABLE